| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |